- Has physical offices
- Publicly traded
- Healthtech
- Pharma & life sciences
- International operations
- Has in-house R&D
- Handles regulated data
About DBV Technologies
Develops a skin patch (Viaskin) for treating food allergies and other immune diseases, aiming to re-educate the immune system through the skin. Pioneering epicutaneous immunotherapy.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Chatillon, Île-de-France, France
- Revenue
- $5.6MFY2025, publicly reported
- SIREN
- 441772522
- Website
- dbv-technologies.com
Who should you contact at DBV Technologies?
Connect to Tamtam to see the decision-makers at DBV Technologies, with verified emails and phone numbers, and find more companies like it.
See who to contact, freeDBV Technologies account plan
DBV Technologies is a French late-stage biopharma developing the Viaskin Peanut patch, with a BLA filed at the FDA in September 2026.
Jobs at DBV Technologies
DBV Technologies at a glance
DBV Technologies is a company in the Biotechnology Research industry, headquartered in Chatillon, Île-de-France, France.
DBV Technologies has 51–250 employees.
DBV Technologies's revenue is $5.6M (FY2025, publicly reported).
DBV Technologies's SIREN number is 441772522.
DBV Technologies is hiring: 10 recent open roles, including Senior Director, U.S. Policy & Government Affairs, Director, Internal Communications, Director, Social Media.
Frequently asked questions about DBV Technologies
What is DBV Technologies's revenue?
DBV Technologies's revenue is $5.6M (FY2025, publicly reported).
How many employees does DBV Technologies have?
DBV Technologies has 51–250 employees.
Where is DBV Technologies headquartered?
DBV Technologies is headquartered in Chatillon, Île-de-France, France.
Selling to companies like DBV Technologies?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies